Login
NowRx announces $3mm new loan agreement & campaign closing in 16 days
NowRx is excited to announce $3mm in new funding from Decathlon Capital, a revenue-based capital fund. The revenue-based loan agreement provides NowRx up to $3mm in non-dilutive expansion capital to accelerate the company’s growth plans.
“This is great recognition by a prominent investment fund,” said CEO Cary Breese. “Decathlon’s revenue-based financing enables NowRx to secure additional expansion capital without dilution to our investors, which is a way for us to grow our footprint more rapidly.”
NowRx has surpassed $12.9mm raised and is the company with the most investments currently on SeedInvest. The campaign is ending on Friday, June 19th – there are 16 days left to invest.